Mobile Button Search>
Pre-IND
Phase I
Phase II
Phase III
Registration
Marketed

Hematology

P1101
PV (EU)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (US, TW)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
PV (JP, CN, KR)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

P1101
ET (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

PEG-EPO
Anemia (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Hematology

PEG-GCSF
Neutropenia (Global, exc US)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101
HCV-G2 (DAA non-responder) (TW, KR, CN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101
HBV e+ add on (bio-marker) (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Infectious Disease

P1101 (orphan)
HDV / HBV (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

Oraxol
Breast Cancer (TW, SG, VN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

Oraxol + Ramucirumab
Gastric Cancer (TW, SG, VN)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Oncology

P1101 + PD-1
HCC (Global)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA

Dermatology

KX01
Psoriasis (TW, CN, MY)
Pre-Clinical
Phase I
Phase II
Phase III
NDA
NDA